The Galahad (Glaucoma – Advanced, LAbel-free High resolution Automated OCT Diagnostics) project has received funding from Horizon 2020, the European Union’s Framework Programme for Research and Innovation, under grant agreement No. 732613. Galahad’s primary objective is to improve screening and basic diagnostics for glaucoma, which is a major cause of blindness throughout the world.The project will develop a non-contact method of examining the surface and sub-surface of the retina in real time without the need for anaesthetic.
As a part of this project, Ibsen has designed and built a new spectrometer for ultra-high resolution OCT with broad wavelength range (650-950 nm) and diffraction-limited resolution (better than 0.07 nm). The broad bandwidth of 300 nm and high spectrometer resolution are required to reach an axial resolution of 1 µm and maximum depth of 2 mm in the final OCT system. The spectrometer demonstrates excellent performance and very high temporal and thermal stability. For more info contact Dr. Bjarke Rose.
Following some exciting developments, the final workshop will now include a demonstration on a human retina at “The Royal Society of Edinburgh” on January 8, 2020. You can register to this event for free here.